Dementia Clinical Trials: A Study on the Clinical Trial Participation of Dementia Patients

Power Life Sciences Inc.0 sites500 target enrollmentMay 2024

ConditionsDementia

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Dementia
Sponsor: Power Life Sciences Inc.
Enrollment: 500
Primary Endpoint: Number of dementia patients who remain in clinical trial until completion.
Status: Not yet recruiting
Last Updated: 2 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

This research aims to collect comprehensive data on the clinical trial experience of dementia patients. Its goal is to identify the factors that limit patients' ability to join or complete a trial successfully. Clinical trial participation often favors specific demographic groups, and limited research exists on the impact of trial attributes on participation. Therefore, this study aims to analyze data from various demographic groups and identify any recurring trends that could provide valuable insights for future dementia patients.

Registry

clinicaltrials.gov

Start Date

May 2024

End Date

May 2026

Last Updated

2 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

Power Life Sciences Inc.

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•Ability to provide written informed consent obtained prior to participation in the study and any related procedures being performed.
•Participant has a diagnosis of dementia.
•Willing and able to comply with scheduled visits, treatment schedule, laboratory tests and other requirements of the study.

Exclusion Criteria

•Pregnant or lactating woman
•Enrolled in another research study
•Any mental or medical condition that prevents the patient from giving informed consent or participating in the trial